Welcome to the Center for Targeted Therapeutics and Translational Nanomedicine

CT3N is a joint interdisciplinary venture between the Perelman School of Medicine (PSOM) and the School of Engineering and Applied Science (SEAS), with the mission to facilitate and accelerate translational research in targeted therapeutics and nanomedicines by bringing together the many leading laboratories active in these areas at the University of Pennsylvania, CHOP and surrounding academic institutions.  Research areas being pursued by CT3N faculty include design of biomaterials and carriers for drug delivery, identification of molecular targets for cell-specific delivery, studies of targeting, binding, sub-cellular trafficking and metabolism of targeted drugs. 

Learn more about CT3


CT3N Faculty Publication Highlights

Chen et al., Nature Commun. (2024) 15:5808 / A. Tsourkas lab


Congratulations to Vladimir Muzykantov, MD, PhD, on his Founders Professorship of Nanoparticle Research!

Celebration on January 16th, with Profs. E. John Wherry, Vlad Muzykantov, Drew Weissman, and Jonathan A. Epstein 


Muzykantov lab members and alumni


 

Upcoming Events